Determining the role of TRIM25 in Androgen Receptor- dependent Cancers

ESR5
Christine Blattner

Prostate cancer is one of the leading cancer deaths for men. By applying state-of-the-art techniques in molecular biology and biochemistry, we will investigate how TRIM25 controls androgen receptor activity and proliferation and migration of prostate cancer cells and elucidate its suitability as a target for drug development.

More info